Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

A systematic approach is crucial for managing hair loss in women.

Nonablative radiofrequency treatments, especially microneedle and fractional types, can improve acne scars by 25%–75% after 3-4 sessions, with full results in 3 months and some side effects.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

Stem cell therapy may help treat tough hair loss cases.

Finasteride reduces gambling symptoms in Parkinson's patients.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

Minoxidil helps prevent stress-caused hair loss in mice.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

People with alopecia areata have a higher risk of stroke.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Minoxidil improves quality of life for women with hair loss.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Inositol was not more effective than a placebo in treating trichotillomania.

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.